BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21455105)

  • 1. Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients.
    Piotrowska E; Jakobkiewicz-Banecka J; Maryniak A; Tylki-Szymanska A; Puk E; Liberek A; Wegrzyn A; Czartoryska B; Slominska-Wojewodzka M; Wegrzyn G
    Med Sci Monit; 2011 Apr; 17(4):CR196-202. PubMed ID: 21455105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of elevated doses of genistein-rich soy extract in the gene expression-targeted isoflavone therapy for Sanfilippo disease patients.
    Malinová V; Węgrzyn G; Narajczyk M
    JIMD Rep; 2012; 5():21-5. PubMed ID: 23430913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients.
    Piotrowska E; Jakóbkiewicz-Banecka J; Tylki-Szymanska A; Liberek A; Maryniak A; Malinowska M; Czartoryska B; Puk E; Kloska A; Liberek T; Baranska S; Wegrzyn A; Wegrzyn G
    Curr Ther Res Clin Exp; 2008 Apr; 69(2):166-79. PubMed ID: 24692796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein in Sanfilippo disease: a randomized controlled crossover trial.
    de Ruijter J; Valstar MJ; Narajczyk M; Wegrzyn G; Kulik W; Ijlst L; Wagemans T; van der Wal WM; Wijburg FA
    Ann Neurol; 2012 Jan; 71(1):110-20. PubMed ID: 22275257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy.
    Piotrowska E; Jakóbkiewicz-Banecka J; Wegrzyn G
    Phytother Res; 2010 Jan; 24 Suppl 1():S109-13. PubMed ID: 19610046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein supplementation in patients affected by Sanfilippo disease.
    Delgadillo V; O'Callaghan Mdel M; Artuch R; Montero R; Pineda M
    J Inherit Metab Dis; 2011 Oct; 34(5):1039-44. PubMed ID: 21556833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones.
    Arfi A; Richard M; Gandolphe C; Scherman D
    J Inherit Metab Dis; 2010 Feb; 33(1):61-7. PubMed ID: 20084460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system.
    Kim KH; Dodsworth C; Paras A; Burton BK
    Mol Genet Metab; 2013 Aug; 109(4):382-5. PubMed ID: 23845234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
    Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
    Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose genistein in Sanfilippo syndrome: A randomised controlled trial.
    Ghosh A; Rust S; Langford-Smith K; Weisberg D; Canal M; Breen C; Hepburn M; Tylee K; Vaz FM; Vail A; Wijburg F; O'Leary C; Parker H; Wraith JE; Bigger BW; Jones SA
    J Inherit Metab Dis; 2021 Sep; 44(5):1248-1262. PubMed ID: 34047372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein: a natural isoflavone with a potential for treatment of genetic diseases.
    Wegrzyn G; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Piotrowska E; Narajczyk M; Kloska A; Malinowska M; Dziedzic D; Gołebiewska I; Moskot M; Wegrzyn A
    Biochem Soc Trans; 2010 Apr; 38(2):695-701. PubMed ID: 20298245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
    deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
    Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in hair morphology as a biomarker in gene expression-targeted isoflavone therapy for Sanfilippo disease.
    Narajczyk M; Tylki-Szymańska A; Węgrzyn G
    Gene; 2012 Aug; 504(2):292-5. PubMed ID: 22633875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression-targeted isoflavone therapy.
    Węgrzyn A
    IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT).
    Marucha J; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Piotrowska E; Kloska A; Czartoryska B; Węgrzyn G
    Am J Med Genet A; 2011 Sep; 155A(9):2257-62. PubMed ID: 21834048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
    Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study.
    de Ruijter J; Maas M; Janssen A; Wijburg FA
    Mol Genet Metab; 2013 May; 109(1):49-53. PubMed ID: 23541797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome).
    Valstar MJ; Marchal JP; Grootenhuis M; Colland V; Wijburg FA
    Orphanet J Rare Dis; 2011 Jun; 6():43. PubMed ID: 21689409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III).
    Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR
    Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.